Emirates News Agency on MSN
Burjeel Medical City introduces Gulf’s first chronic sinusitis treatment administered once every six months
ABU DHABI, 7th November, 2026 (WAM) -- Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, has administered Exdensur (depemokimab), an ultra-long-acting biologic treatment for ...
Global ENT endoscopy Market size is expected to be worth around US$ 18.4 Billion by 2035 from US$ 9.9 Billion in 2025 ...
Patients with nasal polyps who receive dupilumab have a lower risk for using antibiotics or steroids early on than those ...
IL-13 and TNF-α gene variants to chronic rhinosinusitis with nasal polyps and comorbid severe asthma, identifying three ...
A readily available blood marker was associated with recurrent nasal polyps after endoscopic sinus surgery, but its ability to improve routine clinical prediction remained modest and uncertain. In a ...
New dose-ranging cohort in FAP builds on compelling early clinical evidence observed with zolucatetide in patients with FAP and concomitant desmoid tumors Zolucatetide directly inhibits β-catenin:TCF, ...
ANTIBODIES DESIGNED to recognise more than one target are being explored as potential treatments for chronic rhinosinusitis with nasal polyps, according to a review examining the rationale for broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results